XENETIC BIOSCIENCES, INC. Interest Payable, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Interest Payable, Current of $0 as of 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2017-03-31
- 2016-12-31: Interest Payable, Current $0.00.
- 2015-12-31: Interest Payable, Current $77.86K.
- 2014-12-31: Interest Payable, Current $0.00.
- 2013-11-30: Interest Payable, Current $32.08K.
| Period end | Interest Payable, Current |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-31 |
| 2015-12-31 | $77.86K 10-K · filed 2017-03-31 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2013-11-30 | $32.08K 10-Q · filed 2014-01-10 |
| 2013-08-31 | $26.38K 10-Q · filed 2014-01-10 |
| 2013-05-31 | $23.15K 10-Q · filed 2013-07-17 |
| 2013-02-28 | $19.92K 10-Q · filed 2013-04-22 |
| 2012-11-30 | $16.76K 10-Q · filed 2013-01-22 |
| 2012-08-31 | $13.56K 10-K · filed 2013-11-27 |
| 2012-05-31 | $10.33K 10-Q · filed 2012-07-16 |
| 2012-02-29 | $7.10K 10-Q · filed 2012-04-24 |
| 2011-08-31 | $548.00 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |